The supply chain that nobody questioned For decades, the global botanical ingredients industry operated on a straightforward model: source raw plant material from tropical and subtropical regions where labour is inexpensive and biodiversity is abundant, process it through a chain of intermediaries, and deliver it to European manufacturers for formulation. The primary selection criteria were price and availability. The system worked well enough when nobody looked too closely a

B Corp is everywhere. But what does it mean for a biotech company producing high-tech botanicals?

The Forgotten Half of the Plant When we think of medicinal plants, we usually picture leaves, flowers, and stems. These aerial parts are the most accessible, the most studied, and the easiest to harvest at scale. But for many therapeutically important species, the root system contains a distinct and often more concentrated set of bioactive compounds that have been largely overlooked by the modern ingredients industry.

The Hidden Problem with Field-Grown Botanicals For centuries, medicinal plants have been cultivated in open fields or collected from the wild. This approach served traditional medicine well, but it falls short of the standards demanded by today’s pharmaceutical, cosmetic, and nutraceutical industries. Field-grown botanical ingredients carry inherent risks: soil-borne contaminants, pesticide residues, heavy metal accumulation, and batch-to-batch variation in active compound c

What Is the Nagoya Protocol and Why Should You Care? The Nagoya Protocol is an international agreement under the Convention on Biological Diversity that governs access to genetic resources and the fair sharing of benefits arising from their use. Adopted in 2010 and entering into force in 2014, it establishes a legal framework requiring that biological materials sourced from signatory countries are obtained with prior informed consent and that benefits from their commercial u

Traceability Is No Longer Optional The days when "natural origin" was a sufficient quality claim for botanical ingredients are over. Today’s regulatory environment, from EU CSRD reporting to tightening pharmacopeial standards, demands that companies demonstrate exactly where their ingredients come from, how they were produced, and what quality controls were applied at every step.